Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | PTGER3 | P43115 | 8/20 | 0.52 |
| ▸ | PTGER2 | P43116 | 8/20 | 0.52 |
| ▸ | PTGER4 | P35408 | 7/20 | 0.52 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | TNKS | O95271 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL690917 | 1.00 | CA1 (0.53) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL30560916 | 1.00 | CA1 (0.53) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL10589353 | 0.85 | NFKB1 (0.69) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL3811894 | 0.84 | PTGER3 (0.50) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL3811892 | 0.84 | PTGER3 (0.50) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL78556 | 0.84 | CA1 (0.62) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL2425317 | 0.84 | CA1 (0.62) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL78555 | 0.84 | CA1 (0.62) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL29386378 | 0.84 | CA1 (0.62) | CA1CA2NFKB1CA4PTGER3 | |
| SCHEMBL11830587 | 0.83 | PTGER3 (0.71) | CA1CA2NFKB1CA4PTGER3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| EP-2268614-B1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2013-05-15 | — | — | EP | claimed |
| US-8258340-B2 | Method for producing β-mercapto carboxylic acids | SHOWA DENKO K.K. (JP) | 2012-09-04 | — | — | US | claimed |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2011-01-20 | — | — | US | claimed |
| EP-2268614-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | Showa Denko K.K. (JP) | 2011-01-05 | — | — | EP | claimed |
| WO-2009113711-A1 | METHOD FOR PRODUCING -MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | WO | claimed |
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | disclosed |
| CN-116768792-B | Cinnamamide-hydroxypyridone derivative, and preparation method and application thereof | 浙江工业大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-116768792-A | Cinnamamide-hydroxypyridone derivative, and preparation method and application thereof | 浙江工业大学 | 2023-09-19 | — | — | CN | disclosed |
| EP-2688554-A2 | OPTIMISED PREPARATIONS OF HIGHLY ADAPTABLE AGGREGATES | Cevc, Gregor (DE) | 2014-01-29 | — | — | EP | disclosed |
| US-20140017302-A1 | OPTIMISED PREPARATIONS OF HIGHLY ADAPTABLE AGGREGATES | CEVC GREGOR (DE) | 2014-01-16 | — | — | US | disclosed |
| EP-2268614-B1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO KK (JP) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012126966-A2 | OPTIMISED PREPARATIONS OF HIGHLY ADAPTABLE AGGREGATES | CEVC GREGOR (DE) | 2012-09-27 | — | — | WO | disclosed |
| WO-2009113711-A1 | METHOD FOR PRODUCING -MERCAPTO CARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009038232-A2 | METHOD FOR PRODUCING BETA-MERCAPTOCARBOXYLIC ACIDS | SHOWA DENKO K.K. (JP) | 2009-03-26 | — | — | WO | disclosed |
| EP-1456165-A1 | INDUCTION OF APOPTOSIS IN CANCER CELLS | The Burnham Institute (US) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003048101-A1 | INDUCTION OF APOPTOSIS IN CANCER CELLS | THE BURNHAM INSTITUTE (US) | 2003-06-12 | — | — | WO | disclosed |
| EP-1100495-A4 | PROPENAMIDES AS CCR5 MODULATORS | SMITHKLINE BEECHAM CORP (US) | 2002-09-25 | — | — | EP | disclosed |
| EP-1100495-A1 | PROPENAMIDES AS CCR5 MODULATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000006153-A1 | PROPENAMIDES AS CCR5 MODULATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140017302-A1 | OPTIMISED PREPARATIONS OF HIGHLY ADAPTABLE AGGREGATES | CD68, CHMP4B, ANXA5 | CA1 3438/4885CA2 2151/4885NFKB1 2639/4885 |
| US-20110015436-A1 | METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS | CBS, ALDH7A1, CBR1 | CA1 349/4885CA2 665/4885NFKB1 3075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.